4.7 Article

Association of Genetic Variants Linked to Late-Onset Alzheimer Disease With Cognitive Test Performance by Midlife

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Genetic Risk of Alzheimer's Disease and Sleep Duration in Non-Demented Elders

Yue Leng et al.

Summary: Growing evidence suggests an association between sleep duration and Alzheimer's disease. This study found that genetic liability for AD may predict sleep duration, with a higher AD-GRS score associated with shorter sleep, especially in those aged 55 and older. Using AD-GRS as an instrumental variable, incipient AD was found to reduce sleep duration by 1.87 hours.

ANNALS OF NEUROLOGY (2021)

Article Clinical Neurology

Identifying Sensitive Measures of Cognitive Decline at Different Clinical Stages of Alzheimer's Disease

Roos J. Jutten et al.

Summary: The study found that commonly used neuropsychological tests differ in their ability to capture cognitive decline at different clinical stages of Alzheimer's disease. Therefore, stage-specific cognitive endpoints are necessary to accurately assess disease progression and increase the chance of successful treatment evaluation.

JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2021)

Article Clinical Neurology

Worth the Wait: Delayed Recall after 1 Week Predicts Cognitive and Medial Temporal Lobe Trajectories in Older Adults

Cutter A. Lindbergh et al.

Summary: The study found that memory recall after a 1-week delay in older adults predicts subsequent changes in brain structure and cognition. Specifically, recall performance after 1 week was associated with decline in medial temporal lobe volumes, episodic memory, and executive functioning, while recall after 30 minutes was only linked to decline in executive functioning.

JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2021)

Article Public, Environmental & Occupational Health

Extension of Mendelian Randomization to Identify Earliest Manifestations of Alzheimer Disease: Association of Genetic Risk Score for Alzheimer Disease With Lower Body Mass Index by Age 50 Years

Willa D. Brenowitz et al.

Summary: This study used Mendelian randomization to estimate that the impact of Alzheimer's disease on body mass index occurs in middle age, leading to weight loss. The divergence in BMI between high-risk and low-risk groups begins after the age of 47.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2021)

Article Clinical Neurology

The Relationship of APOE ε4, Race, and Sex on the Age of Onset and Risk of Dementia

Danielle S. Powell et al.

Frontiers in Neurology (2021)

Article Clinical Neurology

Association of Digital Clock Drawing With PET Amyloid and Tau Pathology in Normal Older Adults

Dorene M. Rentz et al.

Summary: The study aimed to investigate whether the digital clock-drawing test, DCTclock, improves upon standard cognitive assessments for discriminating diagnostic groups and detecting biomarker evidence of amyloid and tau pathology in clinically normal older adults (CN). Results showed that DCTclock had excellent discrimination between diagnostic groups and was associated with greater amyloid and tau burden in CN participants compared to traditional cognitive tests. This suggests that digitized measures like DCTclock could provide an efficient tool for detecting early cognitive changes related to Alzheimer's disease.

NEUROLOGY (2021)

Article Clinical Neurology

Association of genetic risk for Alzheimer disease and hearing impairment

Willa D. Brenowitz et al.

NEUROLOGY (2020)

Article Psychology, Clinical

Effects of APOE on Cognitive Aging in Community-Dwelling Older Adults

Emilie T. Reas et al.

NEUROPSYCHOLOGY (2019)

Article Multidisciplinary Sciences

Age and cognitive decline in the UK Biobank

Marilyn C. Cornelis et al.

PLOS ONE (2019)

Article Clinical Neurology

Alzheimer's Disease Clinical Trials: Moving Toward Successful Prevention

Michael S. Rafii et al.

CNS DRUGS (2019)

Article Multidisciplinary Sciences

Lifespan Changes of the Human Brain In Alzheimer's Disease

Pierrick Coupe et al.

SCIENTIFIC REPORTS (2019)

Article Clinical Neurology

Change in Cognitive Performance From Midlife Into Old Age: Findings from the Midlife in the United States (MIDUS) Study

Matthew L. Hughes et al.

JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2018)

Article Psychiatry

Apolipoprotein-E (Apoe) epsilon 4 and cognitive decline over the adult life course

Mark James Rawle et al.

TRANSLATIONAL PSYCHIATRY (2018)

Article Geriatrics & Gerontology

Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease

Suzanne E. Schindler et al.

NEUROBIOLOGY OF AGING (2017)

Article Public, Environmental & Occupational Health

Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population

Anna Fry et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2017)

Review Clinical Neurology

Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility

Marion Mortamais et al.

ALZHEIMERS & DEMENTIA (2017)

Article Biochemistry & Molecular Biology

Differential effects of the APOE e4 allele on different domains of cognitive ability across the life-course

Riccardo E. Marioni et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2016)

Article Clinical Neurology

Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort

Michelle M. Mielke et al.

ALZHEIMERS & DEMENTIA (2016)

Article Medicine, General & Internal

Incidence of Dementia over Three Decades in the Framingham Heart Study

Claudia L. Satizabal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Clinical Neurology

Trajectories of Alzheimer disease-related cognitive measures in a longitudinal sample

Murat Bilgel et al.

ALZHEIMERS & DEMENTIA (2014)

Article Biochemistry & Molecular Biology

Mendelian randomization: genetic anchors for causal inference in epidemiological studies

George Davey Smith et al.

HUMAN MOLECULAR GENETICS (2014)

Article Geriatrics & Gerontology

APOE Genotype and Cognitive Change in Young, Middle-Aged, and Older Adults Living in the Community

David Bunce et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)

Article Genetics & Heredity

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

Jean-Charles Lambert et al.

NATURE GENETICS (2013)

Article Medicine, General & Internal

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

Randall J. Bateman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Neurosciences

Prediction of Preclinical Alzheimer's Disease: Longitudinal Rates of Change in Cognition

Kathryn P. Riley et al.

JOURNAL OF ALZHEIMERS DISEASE (2011)

Article Geriatrics & Gerontology

The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis

Nick M. Wisdom et al.

NEUROBIOLOGY OF AGING (2011)

Article Biochemical Research Methods

PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations

Joshua C. Denny et al.

BIOINFORMATICS (2010)

Article Medicine, General & Internal

Longitudinal Modeling of Age-Related Memory Decline and the APOE ε4 Effect

Richard J. Caselli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Multidisciplinary Sciences

Distinct patterns of brain activity in young carriers of the APOE-ε4 allele

Nicola Filippini et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Clinical Neurology

Prodromal Alzheimer's Disease: Successive Emergence of the Clinical Symptoms

Helene Amieva et al.

ANNALS OF NEUROLOGY (2008)

Article Medicine, Research & Experimental

ACTIVE: A cognitive intervention trial to promote independence in older adults

JB Jobe et al.

CONTROLLED CLINICAL TRIALS (2001)